NEAT1–SOD2 Axis Confers Sorafenib and Lenvatinib Resistance by Activating AKT in Liver Cancer Cell Lines

Hiroyuki Tsuchiya(Kanazawa University), Kenji Yoshida(Keio University)
Current Issues in Molecular Biology
January 29, 2023
Cited by 24


Related Papers